A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282-Reference-Cited by-同舟云学术

A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282

Published:2005-08 Issue:5 Volume:62 Page:1345-1350
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Cohen Steven J.,Dobelbower Ralph,Lipsitz Stuart,Catalano Paul J.,Sischy Benjamin,Smith Thomas J.,Haller Daniel G.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference21 articles.

1. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer;Burris;J Clin Oncol,1997

3. Pancreatic cancer;Cohen;Curr Treat Options Oncol,2000

4. Mitomycin-C therapy in advanced gastrointestinal cancer;Moertel;JAMA,1968

5. 5-FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer;Buroker;Cancer,1979

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiochemotherapy in Pancreatic Cancer;Current Oncology;2024-06-06

2. Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials;Current Oncology;2023-07-18

3. Machine learning-based prediction of surgical benefit in borderline resectable and locally advanced pancreatic cancer;Journal of Cancer Research and Clinical Oncology;2023-07-06

4. The Connection between Bacteria and Cancer: A Systematic Review of the Current Literature;J BIOL REG HOMEOS AG;2023

5. Machine Learning-Based Prediction of Surgical Benefit in Borderline Resectable and Locally Advanced Pancreatic Cancer;2023-05-24